Dry Eye Disease in the Middle East and Northern Africa: A Position Paper on the Current State and Unmet Needs

References

• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
   PubMed Web of Science ®Google Scholar
• Hynnekleiv L, Magno M, Vernhardsdottir RR, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022;100(8):844–860. doi:10.1111/aos.15159
   PubMed Web of Science ®Google Scholar
• O’Brien PD, Collum LM. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 2004;4(4):314–319. doi:10.1007/s11882-004-0077-2
   PubMed Web of Science ®Google Scholar
• Labetoulle M, Rolando M, Baudouin C, van Setten G. Patients’ perception of DED and its relation with time to diagnosis and quality of life: an international and multilingual survey. Br J Ophthalmol. 2017;101(8):1100–1105. doi:10.1136/bjophthalmol-2016-309193
   PubMed Web of Science ®Google Scholar
• Clegg JP, Guest JF, Lehman A, Smith AF. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol. 2006;13(4):263–274.
   PubMed Web of Science ®Google Scholar
• Bukhari A, Ajlan R, Alsaggaf H. Prevalence of dry eye in the normal population in Jeddah, Saudi Arabia. Orbit. 2009;28(6):392–397. doi:10.3109/01676830903074095
   PubMedGoogle Scholar
• Alshamrani AA, Almousa AS, Almulhim AA, et al. Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol. 2017;24(2):67–73. doi:10.4103/meajo.MEAJO_281_16
   PubMed Web of Science ®Google Scholar
• Sherry A, Aridi M, Ghach W. Prevalence and risk factors of symptomatic dry eye disease in Lebanon. Cont Lens Anterior Eye. 2020;43(4):355–358. doi:10.1016/j.clae.2019.08.001
   PubMed Web of Science ®Google Scholar
• Yasir ZH, Chauhan D, Khandekar R, Souru C, Varghese S. Prevalence and determinants of dry eye disease among 40 years and older population of Riyadh (except capital), Saudi Arabia. Middle East Afr J Ophthalmol. 2019;26(1):27–32. doi:10.4103/meajo.MEAJO_194_18
   PubMed Web of Science ®Google Scholar
• Alkabbani S, Jeyaseelan L, Rao AP, Thakur SP, Warhekar PT. The prevalence, severity, and risk factors for dry eye disease in Dubai - A cross sectional study. BMC Ophthalmol. 2021;21(1):219. doi:10.1186/s12886-021-01978-4
   PubMed Web of Science ®Google Scholar
• Perez VL, Stern ME, Pflugfelder SC. Inflammatory basis for dry eye disease flares. Exp Eye Res. 2020;201:108294. doi:10.1016/j.exer.2020.108294
   PubMed Web of Science ®Google Scholar
• Periman LM, Perez VL, Saban DR, Lin MC, Neri P. The immunological basis of dry eye disease and current topical treatment options. J Ocul Pharmacol Ther. 2020;36(3):137–146. doi:10.1089/jop.2019.0060
   PubMed Web of Science ®Google Scholar
• Kumar NR, Praveen M, Narasimhan R, et al. Tear biomarkers in dry eye disease: progress in the last decade. Indian J Ophthalmol. 2023;71(4):1190. doi:10.4103/IJO.IJO_2981_22
   PubMed Web of Science ®Google Scholar
• Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4):802–812. doi:10.1016/j.jtos.2017.08.003
   PubMed Web of Science ®Google Scholar
• Sun M, Moreno IY, Dang M, Coulson-Thomas VJ. Meibomian gland dysfunction: what have animal models taught us? Int J Mol Sci. 2020;21(22):8822. doi:10.3390/ijms21228822
   PubMed Web of Science ®Google Scholar
• Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472–478. doi:10.1097/ICO.0b013e318225415a
   PubMed Web of Science ®Google Scholar
• Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11):S20–S26. doi:10.1016/j.ophtha.2017.05.031
   PubMed Web of Science ®Google Scholar
• Kim WJ, Ahn YJ, Kim MH, Kim HS, Kim MS, Kim EC. Lipid layer thickness decrease due to meibomian gland dysfunction leads to tear film instability and reflex tear secretion. Ann Med. 2022;54(1):893–899. doi:10.1080/07853890.2022.2056238
   PubMed Web of Science ®Google Scholar
• Li J, Ma J, Hu M, Yu J, Zhao Y. Assessment of tear film lipid layer thickness in patients with Meibomian gland dysfunction at different ages. BMC Ophthalmol. 2020;20(1):394. doi:10.1186/s12886-020-01667-8
   PubMed Web of Science ®Google Scholar
• Covita A CM, Leahy C. Correlation between meibomian gland appearance and tear breakup time using a slit scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 2019;60(9):6793.
   Web of Science ®Google Scholar
• Doctor MB, Basu S. Lacrimal gland insufficiency in aqueous deficiency dry eye disease: recent advances in pathogenesis, diagnosis, and treatment. Semin Ophthalmol. 2022;37(7–8):801–812. doi:10.1080/08820538.2022.2075706
   PubMed Web of Science ®Google Scholar
• Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res. 2006;82(4):588–596. doi:10.1016/j.exer.2005.08.019
   PubMed Web of Science ®Google Scholar
• Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254–1266. doi:10.1111/opo.12888
   PubMed Web of Science ®Google Scholar
• Wan Y, Zhang M, Li X. The global prevalence of dry eye disease and its association with economy: a systematic review. Res Square. 2019;2019:1.
   Google Scholar
• Berg EJ, Ying GS, Maguire MG, et al. Climatic and environmental correlates of dry eye disease severity: a report from the Dry Eye Assessment and Management (DREAM) Study. Transl Vis Sci Technol. 2020;9(5):25. doi:10.1167/tvst.9.5.25
   PubMed Web of Science ®Google Scholar
• Aljarousha MA, Badarudin NE, Che Azemin MZ, Aljeesh Y, Abuimara A. A systematic review on prevalence, risk factors, clinical diagnosis and medical management of dry eye disease in the Arab population. dry eye; artificial tears; contact lenses; glaucoma; Arab population. Afr Vision Eye Health. 2021;80(1):a591. doi:10.4102/aveh.v80i1.591
   Google Scholar
• Gantz L, Rosenfield M. Digital eye strain symptoms during online university learning in Israel and the USA during the COVID-19 pandemic. Invest Ophthalmol Vis Sci. 2021;62(8):1975.
   Web of Science ®Google Scholar
• Ghach W, Bakkar MM, Aridi M, Beshtawi I, Doughaily R, Al-Fayoumi N. Prevalence and behavioral-based risk factors (eye cosmetic and tobacco use) of symptomatic dry eye disease in four Middle Eastern countries: Lebanon, Syria, Jordan, and Palestine. Clin Ophthalmol. 2022;16:3851–3860. doi:10.2147/OPTH.S385040
   PubMed Web of Science ®Google Scholar
• Köksoy Vayısoğlu S, Öncü E, Dursun Ö, Dinç E. Investigation of dry eye symptoms in lecturers by ocular surface disease index. Turk J Ophthalmol. 2019;49(3):142–148. doi:10.4274/tjo.galenos.2018.67915
   PubMedGoogle Scholar
• Binyousef FH, Alruwaili SA, Altammami AF, Alharbi AA, Alrakaf FA, Almazrou AA. Impact of dry eye disease on work productivity among Saudi workers in Saudi Arabia. Clin Ophthalmol. 2021;15:2675–2681. doi:10.2147/OPTH.S313158
   PubMed Web of Science ®Google Scholar
• Labbé A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol. 2013;97(11):1399–1403. doi:10.1136/bjophthalmol-2013-303838
   PubMed Web of Science ®Google Scholar
• Wan KH, Chen LJ, Young AL. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye. 2016;30(12):1558–1567. doi:10.1038/eye.2016.186
   PubMed Web of Science ®Google Scholar
• Al-Dairi W, Al Sowayigh OM, Alkulaib NS, Alsaad A. The relationship of dry eye disease with depression in Saudi Arabia: a cross-sectional study. Cureus. 2020;12(12):1.
   Web of Science ®Google Scholar
• Almutairi R, Algezlan S, Bayamin R, et al. The association between dry eye and sleep quality among the adult population of Saudi Arabia. Cureus. 2022;14(3):1.
   Web of Science ®Google Scholar
• Rana HS, Akella SS, Clabeaux CE, Skurski ZP, Aakalu VK. Ocular surface disease in thyroid eye disease: a narrative review. Ocul Surf. 2022;24:67–73. doi:10.1016/j.jtos.2022.02.001
   PubMed Web of Science ®Google Scholar
• Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjögren’s syndrome. Am J Ophthalmol. 2005;140(5):898–899. doi:10.1016/j.ajo.2005.06.031
   PubMed Web of Science ®Google Scholar
• Ziaragkali S, Kotsalidou A, Trakos N. Dry eye disease in routine rheumatology practice. Mediterr J Rheumatol. 2018;29(3):127–139. doi:10.31138/mjr.29.3.127
   PubMedGoogle Scholar
• Golden MI, Meyer JJ, Patel BC. Dry eye syndrome. In: StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
   Google Scholar
• Ben-Eli H, Aframian DJ, Ben-Chetrit E, et al. Shared medical and environmental risk factors in dry eye syndrome, Sjogren’s syndrome, and B-cell non-Hodgkin lymphoma: a case-control study. J Immunol Res. 2019;2019:9060842. doi:10.1155/2019/9060842
   PubMed Web of Science ®Google Scholar
• Amoatey P, Omidvarborna H, Baawain MS, Al-Mamun A, Bari A, Kindzierski WB. Association between human health and indoor air pollution in the Gulf Cooperation Council (GCC) countries: a review. Rev Environ Health. 2020;35(2):157–171. doi:10.1515/reveh-2019-0065
   PubMed Web of Science ®Google Scholar
• García-Marqués JV, Talens-Estarelles C, García-Lázaro S, Wolffsohn JS, Cerviño A. Systemic, environmental and lifestyle risk factors for dry eye disease in a Mediterranean caucasian population. Cont Lens Anterior Eye. 2022;45(5):101539. doi:10.1016/j.clae.2021.101539
   PubMed Web of Science ®Google Scholar
• Iyer JV, Lee SY, Tong L. The dry eye disease activity log study. ScientificWorldJournal. 2012;2012:589875. doi:10.1100/2012/589875
   PubMed Web of Science ®Google Scholar
• Hereher M, Eissa R, Alqasemi A, El Kenawy AM. Assessment of air pollution at Greater Cairo in relation to the spatial variability of surface urban heat island. Environ Sci Pollut Res Int. 2022;29(15):21412–21425. doi:10.1007/s11356-021-17383-9
   PubMed Web of Science ®Google Scholar
• Yu D, Deng Q, Wang J, et al. Air pollutants are associated with dry eye disease in urban ophthalmic outpatients: a prevalence study in China. J Transl Med. 2019;17(1):46. doi:10.1186/s12967-019-1794-6
   PubMedGoogle Scholar
• Hilmi MR, Kamal K, Ariffin A, et al. Effects of different types of primary pterygium on changes in oculovisual function. Sains Malays. 2020;49:383–388. doi:10.17576/jsm-2020-4902-16
   Web of Science ®Google Scholar
• Hilmi MR, Khairidzan MK, Azemin M. Changes in apical corneal curvature in unilateral primary pterygium and normal adults using simulated-K and corneal irregularity measurement. Internat J Allied Health Sci. 2019;3:588–594.
   Google Scholar
• Azemin MZC, Tamrin MIM, Hilmi MR, Kamal KM. Inter-grader reliability of a supervised pterygium redness grading system. Adv Sci Lett. 2016;22(10):2885–2888. doi:10.1166/asl.2016.7125
   Google Scholar
• Tan J, Vollmer-Conna U, Tat L, Coroneo M. Dry-eye disease in recurrent pterygium. Ophthalmic Res. 2019;61(4):199–203. doi:10.1159/000493544
   PubMed Web of Science ®Google Scholar
• Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511–538. doi:10.1016/j.jtos.2017.05.004
   PubMed Web of Science ®Google Scholar
• Alamri A, Amer KA, Aldosari AA, et al. Assessment of dry eye syndrome among contact lens users in Asir region, Saudi Arabia. Cureus. 2022;14(1):1.
   Web of Science ®Google Scholar
• Mohamed MS, Abu-Steit MH, Shalaby AM, Sherif AM. Evaluation of dry eye syndrome after LASIK and surface ablation: a comparative study. J Egypt Ophthalmol Soc. 2015;108(4):221–226. doi:10.4103/2090-0686.174681
   Google Scholar
• Miura M, Inomata T, Nakamura M, et al. Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmol Ther. 2022;11(4):1309–1332. doi:10.1007/s40123-022-00513-y
   PubMed Web of Science ®Google Scholar
• Toda I. LASIK and the ocular surface. Cornea. 2008;27(Suppl 1):S70–S76. doi:10.1097/ICO.0b013e31817f42c0
   PubMed Web of Science ®Google Scholar
• Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. 2011;152(3):377–384.e2. doi:10.1016/j.ajo.2011.02.026
   PubMed Web of Science ®Google Scholar
• Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the Beaver Dam Offspring Study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799–806. doi:10.1016/j.ajo.2013.12.023
   PubMed Web of Science ®Google Scholar
• Leila K, Gatfaoui F, Mahjoub A, et al. [Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)] Impact du traitement antiglaucomateux et de la pathologie de la surface oculaire sur la qualité de vie des patients glaucomateux dans la région de Sousse (Tunisie). J Fr Ophtalmol. 2019;42(5):464–470. doi:10.1016/j.jfo.2018.06.007
   PubMedGoogle Scholar
• Lajmi H, Hmaied W, Achour BB, Zahaf A. Risk factors for ocular surface disease in Tunisian users of preserved antiglaucomatous eye drops. J Curr Ophthalmol. 2021;33(2):128–135. doi:10.4103/JOCO.JOCO_226_20
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268. doi:10.1001/archopht.118.9.1264
   PubMed Web of Science ®Google Scholar
• Magno MS, Utheim TP, Morthen MK, et al. The relationship between caffeine intake and dry eye disease. Cornea. 2023;42(2):186–193. doi:10.1097/ICO.0000000000002979
   PubMed Web of Science ®Google Scholar
• Kam KW, Di Zazzo A, De Gregorio C, Narang P, Jhanji V, Basu S. A review on drug-induced dry eye disease. Indian J Ophthalmol. 2023;71(4):1263–1269. doi:10.4103/IJO.IJO_2782_22
   PubMed Web of Science ®Google Scholar
• Kamøy B, Magno M, Nøland ST, et al. Video display terminal use and dry eye: preventive measures and future perspectives. Acta Ophthalmol. 2022;100(7):723–739. doi:10.1111/aos.15105
   PubMed Web of Science ®Google Scholar
• Liu J, Dong Y, Wang Y. Vitamin D deficiency is associated with dry eye syndrome: a systematic review and meta-analysis. Acta Ophthalmol. 2020;98(8):749–754. doi:10.1111/aos.14470
   PubMed Web of Science ®Google Scholar
• Aziz BF, Tawfik CA. Prevalence of dry eye disease among healthy Egyptian population. J Egypt Ophthalmol Soc. 2020;113(4):133–141. doi:10.4103/ejos.ejos_29_20
   Google Scholar
• Blachman-Braun R, Del Mazo-Rodríguez RL, López-Sámano G, et al. Hookah, is it really harmless? Respir Med. 2014;108(5):661–667. doi:10.1016/j.rmed.2014.01.013
   PubMed Web of Science ®Google Scholar
• Asbell PA, Maguire MG, Pistilli M, et al. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378(18):1681–1690.
   PubMed Web of Science ®Google Scholar
• Kuklinski EJ, Hom MM, Ying GS, et al. Associations between systemic omega-3 fatty acid levels with moderate-to-severe dry eye disease signs and symptoms at baseline in the Dry Eye Assessment and Management Study. Eye Contact Lens. 2021;47(1):2–7. doi:10.1097/ICL.0000000000000687
   PubMed Web of Science ®Google Scholar
• Bistrian BR. n-3 fatty acid supplementation and dry eye disease. N Engl J Med. 2018;379(7):690–691.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Sebastiani S, et al. Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials. Cornea. 2019;38(5):565–573. doi:10.1097/ICO.0000000000001884
   PubMed Web of Science ®Google Scholar
• Arabi A, Chamoun N, Nasrallah MP, Tamim HM, Karras S. Vitamin D deficiency in Lebanese adults: prevalence and predictors from a cross-sectional community-based study. Int J Endocrinol. 2021;2021:3170129. doi:10.1155/2021/3170129
   PubMed Web of Science ®Google Scholar
• Dawson CR, Daghfous T, Messadi M, Hoshiwara I, Schachter J. Severe endemic trachoma in Tunisia. Br J Ophthalmol. 1976;60(4):245–252. doi:10.1136/bjo.60.4.245
   PubMed Web of Science ®Google Scholar
• Erickson S, Sullivan AG, Abad JC, et al. TFOS: unique challenges and unmet needs for the management of ocular surface diseases throughout the world. Ocul Surf. 2021;22:242–244. doi:10.1016/j.jtos.2021.08.014
   PubMed Web of Science ®Google Scholar
• Bakkar MM, Shihadeh WA, Haddad MF, Khader YS. Epidemiology of symptoms of dry eye disease (DED) in Jordan: a cross-sectional non-clinical population-based study. Cont Lens Anterior Eye. 2016;39(3):197–202. doi:10.1016/j.clae.2016.01.003
   PubMed Web of Science ®Google Scholar
• Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33(2):55–60. doi:10.1016/j.clae.2009.12.010
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615
   PubMedGoogle Scholar
• Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea. 2013;32(9):1204–1210. doi:10.1097/ICO.0b013e318294b0c0
   PubMed Web of Science ®Google Scholar
• McMonnies CW. Measurement of symptoms pre- and post-treatment of dry eye syndromes. Optom Vis Sci. 2016;93(11):1431–1437. doi:10.1097/OPX.0000000000000965
   PubMed Web of Science ®Google Scholar
• Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clin Ophthalmol. 2021;15:3811–3820. doi:10.2147/OPTH.S321591
   PubMed Web of Science ®Google Scholar
• Karson CN. Spontaneous eye-blink rates and dopaminergic systems. Brain. 1983;106(3):643–653. doi:10.1093/brain/106.3.643
   PubMed Web of Science ®Google Scholar
• Su Y, Liang Q, Su G, Wang N, Baudouin C, Labbé A. Spontaneous eye blink patterns in dry eye: clinical correlations. Invest Ophthalmol Vis Sci. 2018;59(12):5149–5156. doi:10.1167/iovs.18-24690
   PubMed Web of Science ®Google Scholar
• Pult H, Bandlitz S. Lid-parallel conjunctival folds and their ability to predict dry eye. Eye Contact Lens. 2018;44(Suppl 2):S113–S119. doi:10.1097/ICL.0000000000000435
   PubMedGoogle Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
   PubMed Web of Science ®Google Scholar
• Ophthalmology AAO. Pterygium - Middle East/North Africa. 2023. Available from: https://www.aao.org/education/topic-detail/pterygium-middle-east-north-africa. Accessed January 31, 2024.
   Google Scholar
• Gupta AKR, Nathwani Y. Correlation between pterygium and dry eye. Kerala J Ophthalmol. 2019;31(3):217–220. doi:10.4103/kjo.kjo_65_19
   Google Scholar
• Baudouin C, Irkeç M, Messmer EM, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmol. 2018;96(2):111–119. doi:10.1111/aos.13436
   PubMed Web of Science ®Google Scholar
• Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117:28–38. doi:10.1016/j.exer.2013.08.010
   PubMed Web of Science ®Google Scholar
• Brott NR, Ronquillo Y. Schirmer Test. In: StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
   Google Scholar
• Herbaut A, Liang H, Denoyer A, Baudouin C, Labbé A. Tear film analysis and evaluation of optical quality: a review of the literature. J Fr Ophtalmol. 2019;42(2):e21–e35. doi:10.1016/j.jfo.2018.12.001
   PubMed Web of Science ®Google Scholar
• Baudouin C, Aragona P, Van Setten G, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168–1176. doi:10.1136/bjophthalmol-2013-304619
   PubMed Web of Science ®Google Scholar
• Al-Maskari AZ, Alarfaj K, Shaheen MS, et al. Middle East preferred practice patterns for dry eye disease: a modified Delphi consensus. Open Ophthalmol J. 2020;15:34–42. doi:10.2174/1874364102115010034
   Web of Science ®Google Scholar
• Barabino S, Benitez-Del-Castillo JM, Fuchsluger T, et al. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification. Eur Rev Med Pharmacol Sci. 2020;24(17):8642–8652. doi:10.26355/eurrev_202009_22801
   PubMed Web of Science ®Google Scholar
• Labetoulle M, Benitez-Del-Castillo JM, Barabino S, et al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022;23(5):2434. doi:10.3390/ijms23052434
   PubMed Web of Science ®Google Scholar
• Murube J, Murube A, Zhuo C. Classification of artificial tears. II: additives and commercial formulas. Adv Exp Med Biol. 1998;438:705–715.
   PubMed Web of Science ®Google Scholar
• Arif FH, Kamal MR, Ithnin MK, et al. Evaluation of 18 artificial tears based on viscosity and pH. Malaysian J Ophthalmol. 2020;2(2):96–111. doi:10.35119/myjo.v2i2.109
   Google Scholar
• Arif FAC, Hilmi MR, Kamal KM. A prospective contralateral eye comparison of the tolerability of two artificial tears with different physical properties in patients with dry eye disease. Med Hypothesis Discov Innov Optom. 2023;4(1):1–6. doi:10.51329/mehdioptometry167
   Google Scholar
• Arif FAC, Hilmi MR, Kamal K, Ithnin M. Comparison of immediate effects on usage of dual polymer artificial tears on changes in tear film characteristics. Mal J Med Health Sci. 2020;17(3):252–258.
   Google Scholar
• Arif FAC, Hilmi MR, Md Rejab NS, Wolffsohn JS. Immediate effects of artificial tears with and without preservatives containing hyaluronic acid and carboxymethyl cellulose. Med Hypothesis Discov Innov Optom. 2023;4(3):102–111. doi:10.51329/mehdioptometry179
   Google Scholar
• Bruix A, Adán A, Casaroli-Marano RP. [Efficacy of sodium carboxymethylcellulose in the treatment of dry eye syndrome] Eficacia de la carboximetilcelulosa sódica para el tratamiento del síndrome del ojo seco. Arch Soc Esp Oftalmol. 2006;81(2):85–92. doi:10.4321/S0365-66912006000200008
   PubMedGoogle Scholar
• Aragona P, Giannaccare G, Mencucci R, Rubino P, Cantera E, Rolando M. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review. Br J Ophthalmol. 2021;105(4):446–453. doi:10.1136/bjophthalmol-2019-315747
   PubMed Web of Science ®Google Scholar
• Camillieri G, Bucolo C, Rossi S, Drago F. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J Ocul Pharmacol Ther. 2004;20(6):548–553. doi:10.1089/jop.2004.20.548
   PubMed Web of Science ®Google Scholar
• Posarelli C, Passani A, Del Re M, et al. Cross-linked hyaluronic acid as tear film substitute. J Ocul Pharmacol Ther. 2019;35(7):381–387. doi:10.1089/jop.2018.0151
   PubMed Web of Science ®Google Scholar
• Aragona P, Simmons PA, Wang H, Wang T. Physicochemical properties of hyaluronic acid-based lubricant eye drops. Transl Vis Sci Technol. 2019;8(6):2. doi:10.1167/tvst.8.6.2
   PubMed Web of Science ®Google Scholar
• Chung SH, Lim SA, Tchach H. Efficacy and safety of carbomer-based lipid-containing artificial tear formulations in patients with dry eye syndrome. Cornea. 2016;35(2):181–186. doi:10.1097/ICO.0000000000000660
   PubMed Web of Science ®Google Scholar
• Baudouin C, Galarreta DJ, Mrukwa-Kominek E, et al. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency. Eur J Ophthalmol. 2017;27(2):122–128. doi:10.5301/ejo.5000883
   PubMed Web of Science ®Google Scholar
• Miháltz K, Faschinger EM, Vécsei-Marlovits PV. Effects of lipid- versus sodium hyaluronate-containing eye drops on optical quality and ocular surface parameters as a function of the meibomian gland dropout rate. Cornea. 2018;37(7):886–892. doi:10.1097/ICO.0000000000001523
   PubMed Web of Science ®Google Scholar
• Bilstein A, Heinrich A, Rybachuk A, Mösges R, Borrelli E. Ectoine in the treatment of irritations and inflammations of the eye surface. Biomed Res Int. 2021;2021:8885032. doi:10.1155/2021/8885032
   PubMed Web of Science ®Google Scholar
• Mencucci R, Favuzza E, Bottino P, et al. A new ophthalmic formulation containing antiseptics and dexpanthenol: in vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells. Exp Eye Res. 2020;201:108269. doi:10.1016/j.exer.2020.108269
   PubMed Web of Science ®Google Scholar
• Fogagnolo P, De Cilla S, Alkabes M, Sabella P, Rossetti L. A review of topical and systemic vitamin supplementation in ocular surface diseases. Nutrients. 2021;13(6):1998. doi:10.3390/nu13061998
   PubMed Web of Science ®Google Scholar
• Göbbels M, Gross D. [Clinical study of the effectiveness of a dexpanthenol containing artificial tears solution (Siccaprotect) in treatment of dry eyes] Klinische Studie zur Wirksamkeit eines dexpanthenolhaltigen Tränenersatzmittels (Siccaprotect) bei der Behandlung Trockener Augen. Klin Monbl Augenheilkd. 1996;209(2–3):84–88. doi:10.1055/s-2008-1035283
   PubMedGoogle Scholar
• Romano MR, Biagioni F, Carrizzo A, et al. Effects of vitamin B12 on the corneal nerve regeneration in rats. Exp Eye Res. 2014;120:109–117. doi:10.1016/j.exer.2014.01.017
   PubMed Web of Science ®Google Scholar
• Versura P, Profazio V, Giannaccare G, Fresina M, Campos EC. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye. Eur J Ophthalmol. 2013;23(4):488–495. doi:10.5301/ejo.5000267
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628. doi:10.1016/j.jtos.2017.05.006
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Donnenfeld ED, Holland EJ, et al. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014;40(5):289–296. doi:10.1097/ICL.0000000000000049
   PubMed Web of Science ®Google Scholar
• Byun YJ, Kim TI, Kwon SM, et al. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye. Cornea. 2012;31(5):509–513. doi:10.1097/ICO.0b013e31818c69ef
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138(3):444–457. doi:10.1016/j.ajo.2004.04.052
   PubMed Web of Science ®Google Scholar
• Villani E, Garoli E, Termine V, Pichi F, Ratiglia R, Nucci P. Corneal confocal microscopy in dry eye treated with corticosteroids. Optom Vis Sci. 2015;92(9):e290–295. doi:10.1097/OPX.0000000000000600
   PubMed Web of Science ®Google Scholar
• Beckman K, Katz J, Majmudar P, Rostov A. Loteprednol etabonate for the treatment of dry eye disease. J Ocul Pharmacol Ther. 2020;36(7):497–511. doi:10.1089/jop.2020.0014
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, López-Miguel A, González-García MJ, et al. Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial. Ophthalmology. 2016;123(1):141–153. doi:10.1016/j.ophtha.2015.09.029
   PubMed Web of Science ®Google Scholar
• Bucolo C, Fidilio A, Fresta CG, et al. Ocular pharmacological profile of hydrocortisone in dry eye disease. Front Pharmacol. 2019;10:1240. doi:10.3389/fphar.2019.01240
   PubMed Web of Science ®Google Scholar
• Kallab M, Szegedi S, Hommer N, et al. Topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye: a randomized clinical trial. Adv Ther. 2020;37(1):329–341. doi:10.1007/s12325-019-01137-8
   PubMed Web of Science ®Google Scholar
• Chen M, Gong L, Sun X, et al. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial. J Ocul Pharmacol Ther. 2010;26(4):361–366. doi:10.1089/jop.2009.0145
   PubMed Web of Science ®Google Scholar
• Baiza-Durán L, Medrano-Palafox J, Hernández-Quintela E, et al. A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome. Br J Ophthalmol. 2010;94(10):1312–1315. doi:10.1136/bjo.2008.150011
   PubMed Web of Science ®Google Scholar
• Sacchetti M, Mantelli F, Lambiase A, Mastropasqua A, Merlo D, Bonini S. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. Br J Ophthalmol. 2014;98(8):1016–1022. doi:10.1136/bjophthalmol-2013-304072
   PubMed Web of Science ®Google Scholar
• Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf. 2015;13(3):213–225. doi:10.1016/j.jtos.2014.12.006
   PubMed Web of Science ®Google Scholar
• Holland EJ, Donnenfeld ED, Lindstrom RL, Pflugfelder SC, Sheppard JD, Solomon KD. Expert consensus in the treatment of dry eye inflammation. Based on the proceedings of a symposium held during the 2006 American Academy of Ophthalmology joint meeting. Ophthalmol Times. 2007;32(Supplement 7):1.
   Google Scholar
• Abud TB, Amparo F, Saboo US, et al. A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology. 2016;123(7):1449–1457. doi:10.1016/j.ophtha.2016.02.044
   PubMed Web of Science ®Google Scholar
• Miyazaki D, Fukushima A, Ohashi Y, et al. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Ophthalmology. 2017;124(3):287–294. doi:10.1016/j.ophtha.2016.11.002
   Web of Science ®Google Scholar
• Heikal MA, Soliman TT, Abousaif WS, Shebl AA. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):353–361. doi:10.1007/s00417-021-05356-0
   Web of Science ®Google Scholar
• Moawad P, Shamma R, Hassanein D, Ragab G, El Zawahry O. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome. Eur J Ophthalmol. 2022;32(1):673–679. doi:10.1177/1120672121992680
   PubMed Web of Science ®Google Scholar
• Holland EJ, Luchs J, Karpecki PM, et al. Lifitegrast for the treatment of dry eye disease: results of a Phase III, randomized, double-masked, placebo-controlled trial (OPUS-3). Ophthalmology. 2017;124(1):53–60. doi:10.1016/j.ophtha.2016.09.025
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Torkildsen GL, Lonsdale JD, et al. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 Phase 3 study. Ophthalmology. 2014;121(2):475–483. doi:10.1016/j.ophtha.2013.09.015
   PubMed Web of Science ®Google Scholar
• Tauber J, Karpecki P, Latkany R, et al. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized Phase III OPUS-2 study. Ophthalmology. 2015;122(12):2423–2431. doi:10.1016/j.ophtha.2015.08.001
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci. 2017;56(4):595–604. doi:10.1016/j.transci.2017.07.023
   PubMed Web of Science ®Google Scholar
• Christen WG, Cook NR, Manson JE, et al. Efficacy of marine ω-3 fatty acid supplementation vs placebo in reducing incidence of dry eye disease in healthy US adults: a randomized clinical trial. JAMA Ophthalmol. 2022;140(7):707–714. doi:10.1001/jamaophthalmol.2022.1818
   Web of Science ®Google Scholar
• Best AL, Labetoulle M, Legrand M, M’Garrech M, Barreau E, Rousseau A. [Punctal and canalicular plugs: indications, efficacy and safety (French translation of the article)] Les bouchons lacrymaux: indications, efficacité et tolérance. J Fr Ophtalmol. 2019;42(4):404–414. doi:10.1016/j.jfo.2018.10.003
   PubMed Web of Science ®Google Scholar
• Sharma N, Sah R, Priyadarshini K, Titiyal JS. Contact lenses for the treatment of ocular surface diseases. Indian J Ophthalmol. 2023;71(4):1135–1141. doi:10.4103/IJO.IJO_17_23
   Web of Science ®Google Scholar
• Vazirani J, Sridhar U, Gokhale N, Doddigarla VR, Sharma S, Basu S. Autologous serum eye drops in dry eye disease: preferred practice pattern guidelines. Indian J Ophthalmol. 2023;71(4):1357–1363. doi:10.4103/IJO.IJO_2756_22
   Web of Science ®Google Scholar
• Pan Q, Angelina A, Marrone M, Stark WJ, Akpek EK. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2017;2(2):Cd009327. doi:10.1002/14651858.CD009327.pub3
   PubMed Web of Science ®Google Scholar
• Beining MW, Magnø MS, Moschowits E, et al. In-office thermal systems for the treatment of dry eye disease. Surv Ophthalmol. 2022;67(5):1405–1418. doi:10.1016/j.survophthal.2022.02.007
   Web of Science ®Google Scholar
• Arita R, Fukuoka S. Non-pharmaceutical treatment options for meibomian gland dysfunction. Clin Exp Optom. 2020;103(6):742–755. doi:10.1111/cxo.13035
   PubMed Web of Science ®Google Scholar
• Leng X, Shi M, Liu X, Cui J, Sun H, Lu X. Intense pulsed light for meibomian gland dysfunction: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):1–10. doi:10.1007/s00417-020-04834-1
   PubMed Web of Science ®Google Scholar
• Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea. 2010;29(10):1145–1152. doi:10.1097/ICO.0b013e3181d836f3
   PubMed Web of Science ®Google Scholar
• Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(4):2050–2064. doi:10.1167/iovs.10-6997g
   PubMed Web of Science ®Google Scholar
• Garcia-Zalisnak D, Nash D, Yeu E. Ocular surface diseases and corneal refractive surgery. Curr Opin Ophthalmol. 2014;25(4):264–269. doi:10.1097/ICU.0000000000000077
   PubMed Web of Science ®Google Scholar
• Denoyer A, Landman E, Trinh L, Faure JF, Auclin F, Baudouin C. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK. Ophthalmology. 2015;122(4):669–676. doi:10.1016/j.ophtha.2014.10.004
   PubMed Web of Science ®Google Scholar
• Ambrósio R Jr, Tervo T, Wilson SE. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg. 2008;24(4):396–407.
   PubMed Web of Science ®Google Scholar
• Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF. The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye. Clin Ophthalmol. 2017;11:1423–1430. doi:10.2147/OPTH.S120159
   PubMed Web of Science ®Google Scholar
• Rochet E, Levron A, Agard E, et al. Should artificial tears be used during the preoperative assessment of toric IOLs before age-related cataract surgery? The TORIDE study. J Refract Surg. 2021;37(11):759–766. doi:10.3928/1081597X-20210826-01
   Web of Science ®Google Scholar
• Labetoulle M, Rousseau A, Baudouin C. Management of dry eye disease to optimize cataract surgery outcomes: two tables for a daily clinical practice. J Fr Ophtalmol. 2019;42(8):907–912. doi:10.1016/j.jfo.2019.03.032
   PubMed Web of Science ®Google Scholar
• ASCRS Preoperative OSD Algorithm. American society of cataract and refractive surgery; 2022. Available from: https://ascrs.org/clinical-education/cornea/ascrs-preoperative-osd-algorithm. Accessed January 31, 2024.
   Google Scholar
• Blazey P, Crossley KM, Ardern CL, van Middelkoop M, Scott A, Khan KM. It is time for consensus on ‘consensus statements’. Br J Sports Med. 2022;56(6):306–307. doi:10.1136/bjsports-2021-104578
   Web of Science ®Google Scholar
• Beighton D. Consensus statements. Caries Res. 2017;51(5):1–2. doi:10.1159/000480305
   Web of Science ®Google Scholar